These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 26547049)
21. Outcomes after coronary artery calcium and other cardiovascular biomarker testing among asymptomatic medicare beneficiaries. Shreibati JB; Baker LC; McConnell MV; Hlatky MA Circ Cardiovasc Imaging; 2014 Jul; 7(4):655-62. PubMed ID: 24777939 [TBL] [Abstract][Full Text] [Related]
22. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy. Ess SM; Szucs TD Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529 [TBL] [Abstract][Full Text] [Related]
23. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions. Kang HY; Ko SK; Liew D Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032 [TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland. Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113 [TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease. Venkataraman P; Kawakami H; Huynh Q; Mitchell G; Nicholls SJ; Stanton T; Tonkin A; Watts GF; Marwick TH; JACC Cardiovasc Imaging; 2021 Jun; 14(6):1206-1217. PubMed ID: 33454262 [TBL] [Abstract][Full Text] [Related]
26. Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. McEvoy JW; Nasir K; DeFilippis AP; Lima JA; Bluemke DA; Hundley WG; Barr RG; Budoff MJ; Szklo M; Navas-Acien A; Polak JF; Blumenthal RS; Post WS; Blaha MJ Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1002-10. PubMed ID: 25745060 [TBL] [Abstract][Full Text] [Related]
27. Mediation of cardiovascular risk factor effects through subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Yeboah J; Delaney JA; Nance R; McClelland RL; Polak JF; Sibley CT; Bertoni A; Burke GL; Carr JJ; Herrington DM Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1778-83. PubMed ID: 24876350 [TBL] [Abstract][Full Text] [Related]
28. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. Sillesen H; Muntendam P; Adourian A; Entrekin R; Garcia M; Falk E; Fuster V JACC Cardiovasc Imaging; 2012 Jul; 5(7):681-9. PubMed ID: 22789936 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of new cardiac and vascular rehabilitation strategies for patients with coronary artery disease. Spronk S; Bosch JL; Ryjewski C; Rosenblum J; Kaandorp GC; White JV; Hunink MG PLoS One; 2008; 3(12):e3883. PubMed ID: 19065259 [TBL] [Abstract][Full Text] [Related]
31. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Pletcher MJ; Lazar L; Bibbins-Domingo K; Moran A; Rodondi N; Coxson P; Lightwood J; Williams L; Goldman L Ann Intern Med; 2009 Feb; 150(4):243-54. PubMed ID: 19221376 [TBL] [Abstract][Full Text] [Related]
32. Ankle-brachial index and its link to automated carotid ultrasound measurement of intima-media thickness variability in 500 Japanese coronary artery disease patients. Ikeda N; Araki T; Sugi K; Nakamura M; Deidda M; Molinari F; Meiburger KM; Acharya UR; Saba L; Bassareo PP; Di Martino M; Nagashima Y; Mercuro G; Nakano M; Nicolaides A; Suri JS Curr Atheroscler Rep; 2014 Mar; 16(3):393. PubMed ID: 24425062 [TBL] [Abstract][Full Text] [Related]
33. A systematic review and economic evaluation of statins for the prevention of coronary events. Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: a health technology assessment report. Schnell-Inderst P; Schwarzer R; Göhler A; Grandi N; Grabein K; Stollenwerk B; Manne J; Klauss V; Siebert U; Wasem J Int J Technol Assess Health Care; 2010 Jan; 26(1):30-9. PubMed ID: 20059778 [TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model. Xing Y; Qiu Y; Yang L; Yuan Z; Wang Y Int J Cardiol; 2023 Jan; 371():420-426. PubMed ID: 36228765 [TBL] [Abstract][Full Text] [Related]
36. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Lin JS; Evans CV; Johnson E; Redmond N; Coppola EL; Smith N JAMA; 2018 Jul; 320(3):281-297. PubMed ID: 29998301 [TBL] [Abstract][Full Text] [Related]
37. Gender-specific risk factors for peripheral artery disease in a voluntary screening population. Hiramoto JS; Katz R; Weisman S; Conte M J Am Heart Assoc; 2014 Mar; 3(2):e000651. PubMed ID: 24627420 [TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA). Roberts ET; Horne A; Martin SS; Blaha MJ; Blankstein R; Budoff MJ; Sibley C; Polak JF; Frick KD; Blumenthal RS; Nasir K PLoS One; 2015; 10(3):e0116377. PubMed ID: 25786208 [TBL] [Abstract][Full Text] [Related]